News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
Oryzon Genomics SA
ORYZON publishes paper in Journal of Clinical Oncology demonstrating relevance of iadademstat in leukemia
Paper describes mechanism of differentiation in patients and first antileukemic responses
Ona Therapeutics is named as one of Fierce Biotech’s “Fierce 15” Biotech Companies of 2020
Ona Therapeutics is named as one of Fierce Biotech’s “Fierce 15” Biotech Companies of 2020
Designating it as one of the most promising private biotechnology companies in the industry
Oryzon
ORYZON presents efficacy and safety results of its CLEPSIDRA trial with iadademstat in ED-SCLC patients at ESMO-2020
Triple combination of iadademstat plus carboplatin-etoposide produced an objective response rate of…
Oryzon
Oryzon to present at upcoming international conferences
The company will present at several reputed international conferences in September, all of them to…
AseBio Investor Day 2020
AseBio Investor Day
International
AseBio Investor Day is largest investment event for the biotech industry in Spain
Algenex and Global DX sign agreement to develop and commercialize diagnostic products for the detection of African Swine Fever
Algenex and Global DX sign agreement to develop and commercialize diagnostic products for the detection of African Swine Fever
The first product to be developed will be a point-of-care rapid diagnostic test to identify pigs…
Funding will help advance development of company’s  Myotonic Dystrophy therapy
Arthex secures €4.25M from Invivo Ventures and Advent France Biotechnology
This round completes an initial seed round of €2.7 million ($3.1M) brought by Invivo and CDTI-…
Tasks in the cleanroom
CDTI invests together with Inveready Biotech III and EASO Ventures in VIVEbiotech
A biotechnology startup that develops and produces viral vectors to be applied in gene therapy
CARB-X is funding Spanish biotech Vaxdyn to develop a new vaccine to prevent superbug infections that cause life-threatening pneumonia and other deadly infections
CARB-X is funding Spanish biotech Vaxdyn to develop a new vaccine to prevent superbug infections that cause life-threatening pneumonia and other deadly infections
Vaxdyn’s new vaccine against Gram-negative pathogens, if approved, would help curb the rising…